Gradient variability coefficient: a novel method for assessing glycemic variability and risk of hypoglycemia

Area of Science:

• Endocrinology
• Metabolic Disorders
• Diabetes Technology

Background:

• Glycemic variability and hypoglycemia are clinically significant in diabetes management.
• Current methods lack consensus for simultaneously assessing glycemic variability and hypoglycemia risk.

Purpose of the Study:

• To introduce and evaluate a novel metric, the gradient variability coefficient (GVC).
• To assess GVC's ability to characterize glycemic variability and predict hypoglycemia risk.

Main Methods:

• Utilized 208 daily continuous glucose monitoring (CGM) records from T1DM patients and 2380 from T2DM patients.
• Employed simulated CGM waveforms to compare GVC with standard metrics (SD, CV, MAGE).
• Evaluated GVC's hypoglycemia prediction accuracy using receiver operating characteristic (ROC) curves.

Main Results:

• GVC effectively captures both amplitude and frequency of glucose oscillations, outperforming SD, CV, and MAGE.
• ROC analysis showed strong performance for GVC in predicting hypoglycemia, with AUC of 0.827 (T1DM) and 0.873 (T2DM).

Conclusions:

• The gradient variability coefficient (GVC) shows potential as a clinically valuable tool.
• GVC can aid in characterizing glycemic variability and assessing hypoglycemia risk in diabetes patients.